The dermatology market is a $16 billion market that is expected to grow at a 2.3 percent compounded annual growth rate through 2024 These attractive market characteristics are a natural pull for return-driven investors focused on growing markets.
Globally, skin diseases have become a serious impact on people’s quality of life, causing productivity lost at work and other places, and discrimination due to disfigurement. Skin changes may also indicate the presence of more serious skin disorders that require treatment.
OmegaSkin has shown the ability to heal full thickness wounds with minimal to no scarring. The patient will benefit with fully functioning hair follicles and sweat glands, thus creating a natural plant-based skin that heals with a better aesthetic appearance than conventional bandages and coverings. This makes OmegaSkin a valuable asset for the Dermatologist to treat conditions and procedures such as:
- Skin biopsy.
- Shave removal.
- Topical chemotherapy.
- Photodynamic therapy.
- Electrodessication and curettage.
- Conservative excision.
- Mohs micrographic surgery.
- Post laser ablation recovery.
- Nevus removal.
NeuEsse’ portable hand-held electrospinner is capable of administering liquid OmegaSkin at the site of any of these procedures. Other therapeutics such as hyaluronic acid can be delivered in the exam room.